Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation

PLoS One. 2016 Jul 25;11(7):e0159524. doi: 10.1371/journal.pone.0159524. eCollection 2016.

Abstract

Non-alcoholic fatty liver disease has become the leading liver disease in North America and is associated with the progressive inflammatory liver disease non-alcoholic steatohepatitis (NASH). Considerable effort has been made to understand the role of resident and recruited macrophage populations in NASH however numerous questions remain. Our goal was to characterize the dynamic changes in liver macrophages during the initiation of NASH in a murine model. Using the methionine-choline deficient diet we found that liver-resident macrophages, Kupffer cells were lost early in disease onset followed by a robust infiltration of Ly-6C+ monocyte-derived macrophages that retained a dynamic phenotype. Genetic profiling revealed distinct patterns of inflammatory gene expression between macrophage subsets. Only early depletion of liver macrophages using liposomal clodronate prevented the development of NASH in mice suggesting that Kupffer cells are critical for the orchestration of inflammation during experimental NASH. Increased understanding of these dynamics may allow us to target potentially harmful populations whilst promoting anti-inflammatory or restorative populations to ultimately guide the development of effective treatment strategies.

MeSH terms

  • Adaptive Immunity
  • Animals
  • Biomarkers
  • Chemotaxis, Leukocyte / immunology
  • Cluster Analysis
  • Diet
  • Disease Models, Animal
  • Gene Expression Profiling
  • Immunity, Innate
  • Kupffer Cells / metabolism*
  • Kupffer Cells / pathology
  • Liver / metabolism*
  • Liver / pathology*
  • Liver Function Tests
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / metabolism
  • Macrophages / metabolism
  • Macrophages / pathology
  • Mice
  • Monocytes / metabolism
  • Monocytes / pathology
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Transcriptome

Substances

  • Biomarkers

Grants and funding

DTR – Natural Sciences and Engineering Research Council of Canada Postgraduate Doctoral Scholarship, Alberta Innovates Technology Futures Graduate Scholarship, Cumming School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BE—Canadian Institutes of Health Research Signature Initiative Team Grant in Health Challenges in Chronic Inflammation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.